Wikidata

(Q86108323)

English

A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes

scientific article published on 10 September 2015

In more languages

Statements

title
A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
26358288
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26358288%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q86108323&oldid=2145722513"